Bnp Paribas Asset Management Holding S.A. Bei Gene, Ltd. Transaction History

Bnp Paribas Asset Management Holding S.A.

$40.3 Billion
Q4 2024

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 80,044 shares of BGNE stock, worth $18.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

80,044

Previous 97,895 18.23%

Holding current value

$18.1 Million

Previous $22 Million 32.73%

% of portfolio

0.04%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$174.72 - $246.04 $3.12 Million - $4.39 Million	-17,851 Reduced 18.23%	80,044 $14.8 Million
Q3 2024 Nov 08, 2024	BUY	$143.93 - $224.51 $38,285 - $59,719	266 Added 0.27%	97,895 $22 Million
Q2 2024 Jul 29, 2024	SELL	$129.52 - $174.32 $57,506 - $77,398	-444 Reduced 0.45%	97,629 $13.9 Million
Q1 2024 May 08, 2024	SELL	$141.8 - $181.47 $694,394 - $888,658	-4,897 Reduced 4.76%	98,073 $15.3 Million
Q4 2023 Feb 09, 2024	BUY	$158.67 - $201.58 $1.13 Million - $1.44 Million	7,130 Added 7.44%	102,970 $18.6 Million
Q3 2023 Nov 13, 2023	BUY	$179.87 - $225.13 $329,521 - $412,438	1,832 Added 1.95%	95,840 $17.2 Million
Q2 2023 Aug 08, 2023	BUY	$178.3 - $266.78 $149,237 - $223,294	837 Added 0.9%	94,008 $16.8 Million
Q1 2023 May 08, 2023	SELL	$215.53 - $274.5 $363,383 - $462,807	-1,686 Reduced 1.78%	93,171 $20.1 Million
Q4 2022 Feb 09, 2023	BUY	$125.51 - $229.3 $2.29 Million - $4.18 Million	18,217 Added 23.77%	94,857 $20.9 Million
Q3 2022 Nov 10, 2022	SELL	$131.8 - $202.24 $213,779 - $328,033	-1,622 Reduced 2.07%	76,640 $10.3 Million
Q2 2022 Aug 04, 2022	SELL	$121.11 - $216.05 $10.7 Million - $19.1 Million	-88,622 Reduced 53.1%	78,262 $12.7 Million
Q1 2022 May 12, 2022	BUY	$146.52 - $269.56 $141,538 - $260,394	966 Added 0.58%	166,884 $31.5 Million
Q4 2021 Feb 09, 2022	BUY	$248.56 - $389.34 $2.24 Million - $3.5 Million	8,993 Added 5.73%	165,918 $45 Million
Q3 2021 Nov 08, 2021	BUY	$249.6 - $403.14 $22.8 Million - $36.9 Million	91,527 Added 139.95%	156,925 $57 Million
Q2 2021 Aug 05, 2021	BUY	$292.75 - $367.01 $19.1 Million - $24 Million	65,398 New	65,398 $22.4 Million
Q4 2020 Feb 12, 2021	SELL	$221.31 - $316.61 $2.63 Million - $3.77 Million	-11,893 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$189.18 - $286.44 $192,585 - $291,595	1,018 Added 9.36%	11,893 $3.41 Million
Q2 2020 Aug 04, 2020	BUY	$123.9 - $195.41 $25,771 - $40,645	208 Added 1.95%	10,875 $2.05 Million
Q1 2020 May 12, 2020	BUY	$121.84 - $173.19 $248,309 - $352,961	2,038 Added 23.62%	10,667 $1.31 Million
Q4 2019 Feb 11, 2020	BUY	$115.78 - $208.34 $233,991 - $421,055	2,021 Added 30.58%	8,629 $1.43 Million
Q3 2019 Nov 12, 2019	BUY	$120.61 - $148.29 $54,033 - $66,433	448 Added 7.27%	6,608 $809,000
Q2 2019 Aug 02, 2019	BUY	$113.99 - $146.86 $104,642 - $134,817	918 Added 17.51%	6,160 $764,000
Q4 2018 Feb 13, 2019	BUY	$107.01 - $175.15 $560,946 - $918,136	5,242 New	5,242 $718,000

Others Institutions Holding BGNE

# of Institutions

251

Shares Held

45.6M

Call Options Held

322K

Put Options Held

144K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Bei Gene, Ltd. Transaction History